CME: Therapeutic Insights in Melasma and Hyperpigmentation Management

EPIDEMIOLOGY, CLINICAL AND HISTOLOGIC FEATURES, AND QUALITY OF LIFE Melasma Melasma is an acquired disorder of hyperpigmentation...

Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry

BACKGROUND Treatment of moderate-to-severe psoriasis often poses a challenge to the physician. 1 Patients with widespread disease frequently fail t...

Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database

Selecting a systemic therapy for a patient with psoriasis is a complex process, based on a variety of factors including psoriasis sever...

A Review of Topical Corticosteroid Foams

Topical corticosteroid ointments, creams, and lotions are efficacious treatments for multiple dermatoses.1 However, adherence to these ...

Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis

Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction

A 21-year-old Naval active duty male presented for his first dermatologic evaluation with the chief complaint of a six-week history of ...

Pre- and Post-Procedural Care Best Practices to Enhance Energy-Based Treatment Outcomes

In recent years, numerous energy-based treatments have emerged for facial rejuvenation. Similarly, new complementary skincare options h...

Do You Know the Most Complete, Targeted Biologic for Psoriasis? The Answer May Surprise You

Think You Know IL-17 Pathway? Think Again

When today’s dermatology residents were born, the concept of psoriasis as a systemic disease was relatively new. Early in the 1980s, topical th...

IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A

Our understanding of psoriasis pathogenesis has evolved over time. Before the 1980s, psoriasis was viewed as a skin-limited disease and...

Treating Acne With Topical Antibiotics

Dear Editor, I write to you to express concern about the recently published article by Bonati and Dover, Treating acne with topical antibiotics: cu...

Use of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections

Cutaneous fungal infections account for 3.5 to 6.5 million office visits per year 1 – despite being common, their diverse presen...

Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis

Psoriasis is a chronic immune mediated disease of inflammatory dermatosis that affects 3.2% of adults in the United States and leads to...

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

Atopic dermatitis (AD) is a clinically defined, chronic skin condition characterized by intense itch, disruption of the skin barrier, a...

Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy

Psoriasis is a life-long disease with a chronic relapsing course, with most patients requiring long-term management. However, disease e...

Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab

Guttate psoriasis is an acute subtype of plaque psoriasis characterized by eruption of small, scaly plaques, and papules, 5 to 10 mm in...